Search Results 971-980 of 18489 for prednisone

1. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Use of systemic corticosteroids (> 10 mg prednisone or equivalent) within 15 days (except for prophylaxis for radiodiagnostic contrast reactions), or other ...

2. A Study Of The Gala Airway Treatment System For The Treatment Of Chronic Bronchitis In The United States - Mayo Clinic

   Subject is taking > 10 mg of prednisolone or prednisone per day. Subject has an implantable cardioverter defibrillator or pacemaker. Subject has a history ...

3. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   Treatment with a stable oral corticosteroid dose of ≤ 15 mg prednisone/day or equivalent during study screening and treatment phase. Negative pregnancy ...

4. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

   * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...

5. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Note: Intranasal and inhaled corticosteroids or systemic corticosteroids at doses that do not exceed 10 mg/day of prednisone or an equivalent corticosteroid are ...

6. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   ... prednisone or equivalent), systemic immunosuppressant medications may be enrolled in the study. The use of corticosteroids (≤ 10 mg oral prednisone or ...

7. Rifampin, isoniazid, and pyrazinamide (oral route) - Side effects & dosage - Mayo Clinic

   Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate. Show More. Other Interactions. Certain medicines should not be used at or ...

8. First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b - Mayo Clinic

   In addition, patients must be either off corticosteroids, or on a stable/decreasing dose of ≤10 mg daily prednisone (or equivalent). Anticonvulsants are ...

9. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   ... prednisone equivalent per day for >21 days during the study - Participants who are pregnant or breastfeeding, or intending to become pregnant during the ...

10. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

    Phase trial treatment. - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone ...